Healthpoint, DFB to pay up to $48M in drug case
(AP)—Healthpoint Ltd. and DFB Pharmaceuticals will pay up to $48 million to settle allegations that Healthpoint marketed a prescription skin ointment without approval from federal regulators.
Dec 6, 2012
0
0